期刊文献+

胃癌活检组织P53、nm23和CD44v6基因蛋白表达临床意义 被引量:2

下载PDF
导出
出处 《临床荟萃》 CAS 北大核心 2001年第8期360-361,共2页 Clinical Focus
  • 相关文献

参考文献9

  • 1Greenblatt MS, Bennett WP,Hollstein, et al. Mutation in the P53tumor supressor gene: clue to cancer etiology andmolecular pathogonsis. Cancer Res,1994,54(18): 4855~4878
  • 2Joypaul BV, Newan EL, Hopwood D, et al. Expression of P53 protein in normal,dysplastic, and malignant gastric mucosa: an immunohistochemical study.JPathol,1993,170(3):279~283
  • 3魏子白,吴云林,翟祖康,王瑞年.胃癌内镜活检组织p53、c-erb-B_2和nm23蛋白检测的临床意义[J].肿瘤,1997,17(2):88-89. 被引量:5
  • 4Helmut EG,Wolfram M, Anke S, et al. The relationship of P53 expression to theprognosis of 418 patients with gastric carcinoma. Cancer, 1995,76(5):720~726
  • 5Kodera Y, Lsobe KI, Yamauchi M, et al. Expression of nm23-H1 RNA levelsin humangastric cancer tissues. Cancer, 1994,73(2):259~265
  • 6Gunthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confersmetastatic potential to rat carcinoma cells.Cell,1991,65(1):13~24
  • 7Heider K, Dammrich J, Skroch P, et al. Differential expression of CD44 splicevariants in intestinal and diffuse type human gastric carcinoma and normal gastric mucosa.Cancer Res, 1994,53(18):4197~4203
  • 8Dammrich J, Vollmers HP, Heider K, et al. Importance of different CD44v6 expressionin human gastric intestinal and diffuse type cancer for metastatic lymphogenic spreading.J Mol Med,1995,73(2):395~402
  • 9Wolfram M, Anke S, Karl H, et al. Expression and prognostic value ofthe CD44splicing variants V5 and V6 in gastric cancer. J Pathol,1997,183(2):222~227

共引文献4

同被引文献19

  • 1杨占凤,林万隆,王晓燕,王允野.Hp感染与胃炎性病变,不典型增生及胃癌关系的研究[J].中国实验诊断学,2004,8(4):373-375. 被引量:10
  • 2上海医科大学《实用内科》编辑委员会.实用内科学[M].北京:人民卫生出版社,1993.1326.
  • 3Potec T, Potec A, Sajin M, et al. Biological prognostic parameters in gastric careinomas [J]. Chirurgia, 2014, 109 (3) : 347-354.
  • 4Bhardwaj V, Noto JM, Wei J, et al. Helicobacter pylori bacteria alter the p53 stress response via ERK-HDM2 pathway [J]. Oncotarget,2015,6(3) :1531-1543.
  • 5Saf C, Gulcan EM, Ozkan F, et al. Assessment of p21, p53 expression, and Ki-67 proliferative activities in the gastric mucosa of children with Helicobacter pylori gastritis[J]. Eur J Gastroenterol Hepatol, 2015,27 (2) : 155-161.
  • 6Fuccio L, Zagari RM, Eusebi LH, et al. Meta analysis: canHelicobacter pylori eradication treatment reduce the risk for gastric cancer[J].Ann Intern Med,2009,151(2) : 121-128.
  • 7Moradi M, Salehi Z, Aminian K, et al. Effects of p53 Codon 72 and MDM2 SNP309 polymorphisms on gastric cancer risk among the Iranian population[J]. Asian Pac J Cancer Prey, 2014,15(17) : 7413-7417.
  • 8Ochiai A, Yamauchi Y, Hirohashi S. p53 mutations in the nonneoplastic mucosa of the human stomach showing intestinal metaplasia[J]. Int J Cancer, 1996,69(1) :28-33.
  • 9Berloco P, Russo F, Cariola F, et al. Low presence of p53 abnormalities in H. pylori-infected gastric mucosa and in gastric adenocarcinoma[J]. J Gastroenterol, 2003,38 (1) : 28- 36.
  • 10Siegel R, Naishadham D, Jemal A. (2012) Cancer statistics [J]. CA Cancer J Clin, 2012, 62(1): 10-29.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部